1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gaspari, Z. Patthy, A. Graf, L. Perczel, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 269 527 537 10.1046/j.0014-2956.2001.02685.x 11856311 Comparative structure analysis of proteinase inhibitors from the desert locust, Schistocerca gregaria. 2002 10.2210/pdb1kgm/pdb pdb_00001kgm 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 3659.175 SERINE PROTEASE INHIBITOR I Residues 57-91 1 syn polymer Schistocerca gregaria chymotrypsin inhibitor (SGCI) no no EVTCEPGTTFKDKCNTCRCGSDGKSAACTLKACPQ EVTCEPGTTFKDKCNTCRCGSDGKSAACTLKACPQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-12-12 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES) SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M] SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI RCSB Y RCSB 2001-11-28 REL REL Solid-phase synthesis, Fmoc strategy, Sequence naturally found in Schistocerca gregaria (desert locust) sample structures with acceptable covalent geometry,structures with the least restraint violations 100 10 2D NOESY 0 3.0 ambient 300 K Structures are based on 526 distance restraints (128 long-range) simulated annealing 5 closest to the average 2.5mM SGCI NA; 90% H2O, 10% D2O 90% H2O/10% D2O Brunger refinement X-PLOR 3.851 Brunger structure solution X-PLOR 3.851 500 Bruker DRX GLU 1 n 1 GLU 1 A VAL 2 n 2 VAL 2 A THR 3 n 3 THR 3 A CYS 4 n 4 CYS 4 A GLU 5 n 5 GLU 5 A PRO 6 n 6 PRO 6 A GLY 7 n 7 GLY 7 A THR 8 n 8 THR 8 A THR 9 n 9 THR 9 A PHE 10 n 10 PHE 10 A LYS 11 n 11 LYS 11 A ASP 12 n 12 ASP 12 A LYS 13 n 13 LYS 13 A CYS 14 n 14 CYS 14 A ASN 15 n 15 ASN 15 A THR 16 n 16 THR 16 A CYS 17 n 17 CYS 17 A ARG 18 n 18 ARG 18 A CYS 19 n 19 CYS 19 A GLY 20 n 20 GLY 20 A SER 21 n 21 SER 21 A ASP 22 n 22 ASP 22 A GLY 23 n 23 GLY 23 A LYS 24 n 24 LYS 24 A SER 25 n 25 SER 25 A ALA 26 n 26 ALA 26 A ALA 27 n 27 ALA 27 A CYS 28 n 28 CYS 28 A THR 29 n 29 THR 29 A LEU 30 n 30 LEU 30 A LYS 31 n 31 LYS 31 A ALA 32 n 32 ALA 32 A CYS 33 n 33 CYS 33 A PRO 34 n 34 PRO 34 A GLN 35 n 35 GLN 35 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N PHE 10 A N PHE 10 A O CYS 17 A O CYS 17 A N ARG 18 A N ARG 18 A O ALA 27 A O ALA 27 1 A A H O GLY SER 20 25 1.44 2 A A H O GLY SER 20 25 1.47 5 A A H O GLY SER 20 25 1.57 7 A A H O GLY SER 20 25 1.56 9 A A H O GLY SER 20 25 1.55 10 A A H O GLY SER 20 25 1.53 1 A ARG 18 0.226 SIDE CHAIN 2 A ARG 18 0.200 SIDE CHAIN 3 A ARG 18 0.289 SIDE CHAIN 4 A ARG 18 0.248 SIDE CHAIN 5 A ARG 18 0.248 SIDE CHAIN 6 A ARG 18 0.318 SIDE CHAIN 7 A ARG 18 0.144 SIDE CHAIN 8 A ARG 18 0.138 SIDE CHAIN 9 A ARG 18 0.123 SIDE CHAIN 10 A ARG 18 0.243 SIDE CHAIN 1 A THR 8 -154.14 -33.31 1 A THR 9 42.65 -172.62 1 A PHE 10 176.52 -173.30 1 A LYS 13 26.66 -105.31 1 A LYS 24 -145.14 11.92 1 A CYS 28 61.87 107.02 1 A LEU 30 57.95 90.25 1 A ALA 32 174.00 150.51 1 A CYS 33 -178.60 97.12 2 A THR 8 -162.51 -34.49 2 A THR 9 41.01 -169.29 2 A PHE 10 176.45 -169.67 2 A LYS 13 34.59 -120.05 2 A ASN 15 -170.81 -92.74 2 A CYS 28 64.66 104.04 2 A THR 29 -75.22 -76.01 2 A LEU 30 22.89 108.25 2 A ALA 32 80.88 145.79 3 A THR 3 -116.83 79.70 3 A THR 8 -154.70 -32.56 3 A THR 9 40.49 -166.10 3 A PHE 10 178.27 -173.51 3 A LYS 13 45.50 -144.20 3 A ASN 15 -149.01 -89.44 3 A LYS 24 -79.16 49.66 3 A SER 25 -168.56 100.30 3 A CYS 28 66.68 140.51 3 A ALA 32 -106.83 -80.20 3 A CYS 33 58.25 165.16 4 A THR 3 -169.09 73.05 4 A THR 8 -147.25 -34.31 4 A THR 9 42.24 -172.28 4 A PHE 10 174.08 -169.38 4 A LYS 13 37.73 -148.02 4 A CYS 14 -81.42 40.12 4 A ASN 15 -172.96 -164.24 4 A LYS 24 -108.00 -93.76 4 A SER 25 -32.25 115.85 4 A LYS 31 -136.81 -46.09 4 A ALA 32 174.97 151.89 4 A PRO 34 -72.10 -89.09 5 A THR 8 -151.95 -24.92 5 A THR 9 45.85 179.45 5 A PHE 10 177.46 -165.75 5 A ASP 12 -150.89 -44.37 5 A LYS 13 -141.61 -138.19 5 A ASN 15 -125.92 -167.60 5 A LEU 30 46.72 73.12 5 A ALA 32 -179.36 -70.63 5 A CYS 33 58.15 150.52 6 A THR 3 -49.38 89.98 6 A THR 8 -149.79 -4.88 6 A THR 9 40.53 -171.88 6 A PHE 10 172.21 178.53 6 A ASP 12 -140.50 -50.15 6 A LYS 13 -135.95 -142.84 6 A ASN 15 -128.21 -89.75 6 A CYS 28 63.05 112.85 6 A LEU 30 44.55 73.06 6 A LYS 31 -112.72 51.64 6 A ALA 32 65.50 152.03 6 A PRO 34 -72.06 -91.35 7 A THR 3 -151.64 44.00 7 A THR 8 -134.43 -32.95 7 A THR 9 45.23 178.25 7 A PHE 10 173.31 -162.58 7 A LYS 13 66.52 -142.55 7 A LYS 24 51.97 19.96 7 A LEU 30 -43.58 93.39 7 A ALA 32 65.13 153.62 7 A CYS 33 -162.79 97.77 8 A THR 3 41.37 72.86 8 A THR 8 -164.90 -31.94 8 A THR 9 46.85 177.24 8 A PHE 10 175.33 -169.73 8 A ASP 12 -142.32 -57.44 8 A LYS 13 -117.65 -133.79 8 A LYS 24 43.64 27.36 8 A CYS 28 59.79 94.84 8 A THR 29 -83.37 44.07 8 A ALA 32 69.80 151.57 9 A VAL 2 58.64 -78.65 9 A THR 3 49.73 90.04 9 A THR 8 -134.25 -30.06 9 A THR 9 42.69 -173.40 9 A PHE 10 173.97 -165.12 9 A LYS 13 -137.18 -127.20 9 A CYS 28 65.35 122.35 9 A LEU 30 59.33 -141.49 9 A LYS 31 57.59 14.36 9 A CYS 33 62.76 131.03 10 A VAL 2 -90.43 -82.65 10 A THR 3 38.07 40.38 10 A THR 8 -162.10 -32.89 10 A THR 9 43.43 -173.59 10 A PHE 10 172.64 178.89 10 A ASP 12 -134.30 -48.19 10 A LYS 13 -126.22 -111.68 10 A ASN 15 -169.22 -88.10 10 A THR 16 175.27 173.41 10 A SER 25 -165.09 102.18 10 A CYS 28 61.24 105.04 10 A LYS 31 -145.52 -41.78 10 A ALA 32 -143.49 -57.68 10 A CYS 33 49.62 98.61 SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI 1 N N disulf 2.022 A CYS 4 A SG CYS 4 1_555 A CYS 19 A SG CYS 19 1_555 disulf 2.022 A CYS 14 A SG CYS 14 1_555 A CYS 33 A SG CYS 33 1_555 disulf 2.020 A CYS 17 A SG CYS 17 1_555 A CYS 28 A SG CYS 28 1_555 HYDROLASE Proteinase inhibitor, SGCI, HYDROLASE SGP1_SCHGR UNP 1 1 O46162 MKLALALCAAFLLVVLVQAEQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPHKREVTCEPGTTFKDKCNTCRCGSDGK SAACTLKACPQK 57 91 1KGM 1 35 O46162 A 1 1 35 3 anti-parallel anti-parallel A PHE 10 A PHE 10 A LYS 11 A LYS 11 A THR 16 A THR 16 A CYS 19 A CYS 19 A ALA 26 A ALA 26 A CYS 28 A CYS 28